In this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Dr Andrew Lindsley, US Medical Director at Amgen and Dr Ash Davé, Director, Medical Value and Population Health at Amgen, to discuss TEZSPIRE® (tezepelumab-ekko).

Check out the full episode with bonus insights:

https://masterthemargin.substack.com/p/one-big-beautiful-bill-what-the-new

Schedule an Rx Assessment:

https://www.sykes-cpa.com/rx-assessment-service/

More resources about this topic:

Podcast - Master The Margin: 2025 Tax Outlook: https://www.sykes-cpa.com/tax-cuts-and-jobs-act-2025-outlook/

Webinar - Tax Cuts and Jobs Act of 2017: Pharmacy Impact and §199A: https://www.sykes-cpa.com/tax-cuts-and-jobs-act-of-2017-pharmacy-impact-and-%c2%a7199a/

Blog – Tax-smart Depreciation on Pharmacy Buildings and Equipment: https://www.sykes-cpa.com/tax-smart-depreciation-on-pharmacy-buildings-and-equipment/

Blog – Maximize Pharmacy State and Local Tax Deductions (SALT): https://www.sykes-cpa.com/maximize-pharmacy-state-and-local-tax-deductions-salt/

Dr. William Soliman is the founder and CEO of the Accreditation Council for Medical Affairs (ACMA). The ACMA is America’s leader in life sciences accreditation, certification & training. Soliman is a former pharmaceutical executive who worked in leadership roles at Merck, Abbvie, Gilead and more. He is considered a pharma industry futurist and has been featured on NewsNation, Fox News, Newsmax, Forbes, Al Jazeera, Yahoo Business TV, ABC News Radio & more. The ACMA established the first ever certification standards in the United States and stands as a benchmark of excellence for prior authorization professionals, reimbursement professionals, pharmaceutical sales professionals, medical science liaisons and medical affairs professionals. Dr. Soliman received his PhD from Columbia University & his BA from New York University.